Abstract

We report the cytotoxic effects obtained in HeLa cells of three newly synthesized platinum complexes containing both an O, O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere, which show, by 1H NMR, negligible reactivity with purine bases. These compounds induce cell death with [Pt( O, O′-acac)(γ-acac)(DMS)] being the most effective (IC 50 = 0.98 ± 0.056 and 1.82 ± 0.023 μM for [Pt( O, O′-acac)(γ-acac)(DMS)] and cisplatin, respectively). About 50% of cells died after 5 h treatment with 100 μM [Pt( O, O′-acac)(γ-acac)(DMS)] whilst a 16 h incubation was required to get the same results using 100 μM cisplatin. Cellular accumulation measurements, after treatment with equimolar drug concentrations, indicated the major lipophilicity and cellular uptake of the new compounds. While the cytotoxicity of cisplatin was due to both intracellular accumulation and DNA binding, that of [Pt( O, O′-acac)(γ-acac)(DMS)] was associated with intracellular Pt accumulation only, since it has low reactivity to DNA in intact cells and in vitro. The reaction of the new complexes with guanosine and 5′-GMP was negligible, whereas the l-methionine instantly reacted with the initial Pt complexes. Both cisplatin and [Pt( O, O′-acac)(γ-acac)(DMS)] induced apoptosis in HeLa cells. [Pt( O, O′-acac)(γ-acac)(DMS)] provoked the early signs of apoptosis induction (cleavage of PARP and activation of caspases-9, -3 and -7) only 1 h after addition of the drug. However, in cisplatin-treated cells, cleavage of PARP was seen after 9 h with activation of caspases also proceeding more slowly. In conclusion, these results indicate that the newly synthesized platinum(II) complexes have high and rapid cytotoxic activity in vitro, and suggest that DNA may not be their primary target.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.